24 September 2026 · 112 min

Dr Mike Israetel: "Everyone Can Look 22 By 2037!" (Here's What Will Do It)

With Mike Israetel · Hosted by Julian Issa

What if vanity was actually the smart way into a longer, healthier life?

THE FULL CONVERSATION, ON VIDEO

Watch the full episode.

Dr Mike Israetel: "Everyone Can Look 22 By 2037!" (Here's What Will Do It)

Open on YouTube

JUMP INTO THE CONVERSATION

Chapters

About this episode

What if vanity was actually the smart way into a longer, healthier life?

This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at agelessrx.com/beyond-tomorrow.

On this episode of Beyond Tomorrow, Dr. Mike Israetel breaks down what's actually happening in his own bloodstream: 5mg/week of tirzepatide year-round, plus retatrutide during fat-loss phases, and why he thinks “GLP-2” is a gray-market marketing term with no basis in real receptor biology. He walks through the non-weight-loss case for these drugs, reduced systemic and neural inflammation, better glucose control, emerging anti-cancer data, and a documented drop in addictive behaviors from gambling to alcohol to cigarettes, before getting honest about the tradeoffs: undernutrition, anhedonia, and a long-term data set that, by his own admission, will never be “complete enough” for some critics.